FDA applicant
Xvivo Perfusion AB
FDA records 5 decisions for Xvivo Perfusion AB (Englewood) from 2010 to 2026: 4 510(k) clearances and 1 original PMA approval. Most are in product codes KDN (System, Perfusion, Kidney) and PHO (Normothermic Preservation System For…). Its devices cite 5 predicates, 2 of them its own earlier devices. 1 recall is linked to its devices.
FDA’s records also spell it “Xvivo Perfusion, Inc.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Xvivo Perfusion AB’s devices, and how often a recall has named them.
FDA decisions per year
1in 2022
2026 so far, outlined.
Recalls per year
1in 2022
Class I Class II/III not classified
Planning a device like Xvivo Perfusion AB’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report